Brian Shay, MD
Urology · Crestview Hills, KYNPI 1770529067
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $10,498 of the $14,452 with a category attached, or 72.6%. 57 manufacturers reported payments, led by Astellas Pharma US Inc at 24.0% of the total. Reporting peaked in 2019 at $5,503 and has fallen 73.0% since, to $1,486 in 2025. Among urology clinicians in KY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 489 payments — averaging $29.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$3K
- Axonics, Inc.$2K
- Dendreon Pharmaceuticals LLC$808
- Bayer$805
- Allen Medical Systems$800
- Hill-rom Services, Inc$650
- plus $6K from 51 others
What the payments were for
- Speaking & faculty fees$3,80026%
- Food & beverage$10,49873%
- Education$1541%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$14,452 in reported general payments places this provider in the 90th percentile of 139 urology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 179 | $113,530 |
| GemtesaVibegron | 116 | $96,628 |
| Tamsulosin Hcl | 568 | $8,189 |
| PremarinEstrogens, Conjugated | 11 | $4,807 |
| Oxybutynin Chloride ErOxybutynin Chloride | 168 | $4,383 |
| Trimethoprim | 70 | $3,931 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 151 | $1,770 |
| Finasteride | 168 | $1,763 |
| Potassium Citrate ErPotassium Citrate | 19 | $1,518 |
| Silodosin | 19 | $1,400 |
| Testosterone Cypionate | 44 | $1,228 |
| Tolterodine Tartrate ErTolterodine Tartrate | 11 | $918 |
| NitrofurantoinNitrofurantoin Macrocrystal | 41 | $823 |
| Tolterodine Tartrate | 13 | $752 |
| Cephalexin | 107 | $720 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $3,473 | $113,530179 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $364 | $96,628116 claims |
| PfizerPremarin | $366 | $4,80711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 139 urology providers in Kentucky.
Other urology in Crestview Hills
- Brooke EdwardsCrestview Hills$45K
- Robert LarkeCrestview Hills$22K
- Michael DusingCrestview Hills$13K
- Christopher CirulliCrestview Hills$7K
- Thomas SlabaughLexington$102K
- Uzoma AneleLouisville$60K
- Lee EvansHopkinsville$56K
- Patrick HensleyLexington$50K
- Stephen MonnigLexington$18K
- Kellen ChoiLouisville$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.